Mostrando 10 resultados de: 18
Filtros aplicados
Publisher
Bone(2)
Journal of Neural Transmission(2)
Pharmacology Biochemistry and Behavior(2)
Behavioural Brain Research(1)
Biomedicines(1)
Área temáticas
Farmacología y terapéutica(16)
Enfermedades(12)
Fisiología humana(12)
Ginecología, obstetricia, pediatría, geriatría(4)
Sistemas fisiológicos específicos de los animales(2)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(18)
ODS 4: Educación de calidad(11)
ODS 12: Producción y consumo responsables(8)
ODS 10: Reducción de las desigualdades(7)
ODS 2: Hambre cero(4)
Origen
scopus(18)
A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior
ArticleAbstract: Most animal studies using methylphenidate (MP) do not administer it the same way it is administeredPalabras claves:Attention Deficit Hyperactivity Disorder, Dopamine transporter, methylphenidate, Psychostimulant, ritalinAutores:Cooper T., David Edward Komatsu, Hadjiargyrou M., Hwang Y., Robison L.S., Steier J., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopusCombined chronic oral methylphenidate and fluoxetine treatment increases CB1 receptor density in the somatosensory forelimb region
ArticleAbstract: Methylphenidate (MP) is a psychostimulant commonly prescribed for attention-deficit/hyperactivity diPalabras claves:Autoradiography, Endocannabinoid, Fluoxetine, methylphenidate, Prozac, ritalinAutores:Abigail M. Lantry, Brittany Richardson, David Edward Komatsu, Hadjiargyrou M., Hamilton J., Huy Lu, Lucy D. Mastrandrea, Matt Marion, Quattrin T., Thanos P.K.Fuentes:scopusChronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions
ArticleAbstract: Methylphenidate (MP) is commonly prescribed to treat attention deficit hyperactivity disorder (ADHD)Palabras claves:Autoradiography, Fluoxetine, methylphenidate, Microglia, neuroinflammation, Serotonin reuptake inhibitorsAutores:Abigail M. Lantry, Ahmed R., Albert Pinhasov, Blum K., Caleigh Hoerner, David Edward Komatsu, George Lagamjis, Hadjiargyrou M., Huy Lu, Igor Elman, Julianna Roeser, Shannon Klein, Thanos P.K.Fuentes:scopusThe Effects of Chronic Psychostimulant Administration on Bone Health: A Review
ReviewAbstract: (1) Background: Methylphenidate (MP) and amphetamine (AMP) are psychostimulants that are widely presPalabras claves:ADHD, amphetamine, dopamine, methylphenidate, Osteoblast, osteoclastAutores:David Edward Komatsu, Faraaz Beg, Hadjiargyrou M., Jacob Aronin, Jessica Nowak, Michael Ferrick, Natasha O’Malley, Quattrin T., Sonja Pavlesen, Thanos P.K.Fuentes:scopusPsychostimulants prescribed to children for ADHD following distal radius fractures significantly reduce bone density as a function of duration
ArticleAbstract: Methylphenidate and mixed amphetamine salts (MAS) are psychostimulant medications widely prescribedPalabras claves:amphetamines, bone, methylphenidate, Pediatrics, Radius, skeletal fractureAutores:Blum K., David Edward Komatsu, Hadjiargyrou M., Layla M. Ortiz, Natasha O'Malley, Thanos P.K.Fuentes:scopusWeekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects
ArticleAbstract: Methylphenidate (MP) is a commonly prescribed psychostimulant for Attention Deficit Hyperactivity DiPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, Depression, methylphenidate, Psychostimulant, ritalin, SOCIAL BEHAVIORAutores:Carias E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Kalinowski L., Martin C., Popoola D., Smith L., Somanesan R., Thanos P.K., Vijayashanthar A.Fuentes:scopusBehavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
ReviewAbstract: The majority of animal studies on methylphenidate (MP) use intraperitoneal (IP) injections, subcutanPalabras claves:ADHD, animal model, Behavior, dopamine, methylphenidate, neurochemistry, Psychostimulant, ritalinAutores:Ahmed R., Arnavut E., Badgaiyan R.D., Blum K., Carvalho A., David Edward Komatsu, Hadjiargyrou M., Lee W.X., Senior D., Thanos P.K.Fuentes:scopusBrief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects
ArticleAbstract: Methylphenidate (MP) is a commonly prescribed psychostimulant to individuals with Attention DeficitPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalinAutores:Carias E., Connor C., David Edward Komatsu, Hadjiargyrou M., Kalinowski L., Mackintosh M., Martin C., Popoola D., Richer K., Smith L., Somanesan R., Thanos P.K.Fuentes:scopusAbstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is a psychostimulant chronically prescribed for the treatment of attention defiPalabras claves:Abstinence, addiction, brain function, FDG, Functional connectivity, glucose utilization, methylphenidate, microPET, PetAutores:Arnavut E., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Rutao Yao, Sajjad M., Thanos P.K., Yao R.Fuentes:scopusAbstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner
ArticleAbstract: Introduction: Methylphenidate (MP) is a widely used psychostimulant prescribed for Attention DeficitPalabras claves:Attention Deficit Hyperactivity Disorder, Cannabinoid receptor 1, Endocannabinoid system, methylphenidate, Psychostimulant, ritalinAutores:Connor C., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Robison L.S., Thanos P.K.Fuentes:scopus